Intrinsic Value of S&P & Nasdaq Contact Us

Ascentage Pharma Group International AAPG NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • CN • USD

SharesGrow Score
53/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$48.00
+77.2%

Over the last 12 months, insiders have made 17 transactions in AAPG stock — 0 buys (valued at RSU Award) and 0 sells (valued at RSU Award).

AAPG Insider Ownership

Top Holder
-
Buys (12 mo)
0
$0.00 value
Sells (12 mo)
0
$0.00 value
12-Month Transaction Activity
Buy 0%
Sell 0%
Recent Transactions (last 12 months)
Date Name Role Type Shares Price Value
2026-03-18 Zhai Yifan Chief Medical Officer Unknown 103,364 - -
2026-03-18 Wei Ren Director Unknown 18,850 $8.14 $153.44K
2026-03-18 Wang Shaomeng Director Unknown 27,965 - -
2026-03-18 Lu Simon Dazhong Director Unknown 27,965 - -
2026-03-18 Ye Changqing Director Unknown 28,850 - -
2026-03-18 Yu Debra Director Unknown 27,965 - -
2026-03-18 Bozilenko Marina Director Unknown 27,965 - -
2026-03-18 Knapp Thomas J SVP/general Counsel Unknown 38,938 - -
2026-03-18 Sidransky David Director Unknown 28,850 - -
2026-03-18 Lippman Marc E Director Unknown 27,965 - -
2026-03-18 Lu Simon Dazhong Director Unknown 63,895 - -
2026-03-18 Yang Dajun Chairman and CEO Unknown 103,364 - -
2026-03-18 Ye Changqing Director Unknown 66,550 - -
2026-03-18 Yu Debra Director Unknown 63,895 - -
2026-03-18 Bozilenko Marina Director Unknown 53,895 $8.14 $438.71K
2026-03-18 Sidransky David Director Unknown 66,550 - -
2026-03-18 Lippman Marc E Director Unknown 63,895 - -
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message